Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 267.3
Key Takeaways
Risk factor
Negligible price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Target Price
The average target price of COH.AX is 301 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Data is available to registered users only
Buy
Sell